PROTEOSTASIS THERAPEUTICS, INC. Uncategorized Contracts & Agreements

28 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Open Market Sale AgreementSM, dated February 10, 2023, by and between Kineta, Inc. and Jefferies LLC
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2023
Second Amendment to Kineta 2010 Plan
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
First Amendment to Kineta 2010 Plan
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
Form of Lock-up Agreement, dated June 5, 2022, by each of the parties named in each agreement therein
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
Form of Kineta Support Agreement, dated June 5, 2022, by and among Yumanity, Kineta and each of the parties named in each agreement therein
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Form of Yumanity Support Agreement, dated June 5, 2022, by and among Kineta, Yumanity and each of the parties named in each agreement therein
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
D. Smith Offer Letter (redacted)
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2021
A. Verma Offer Letter (redacted)
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2021
Open Market Sale Agreement SM, dated April 8, 2021, by and between Yumanity Therapeutics, Inc., and Jefferies LLC
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2021
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2021
Form of Support Agreement, by and between Proteostasis Therapeutics, Inc., Yumanity Therapeutics, Inc. and Yumanity Holdings, LLC
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Form of Yumanity Lock-Up Agreement, dated August 22, 2020, by each of the parties named in each agreement therein
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2020
Form of PTI Lock-Up Agreement, dated August 22, 2020, by each of the parties named in each agreement therein
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2020
Form of Yumanity Support Agreement, dated August 22, 2020, by and between PTI, Yumanity and each of the parties named in each agreement therein
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Form of PTI Support Agreement, dated August 22, 2020, by and between Yumanity, PTI and each of the parties named in each agreement therein
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Form of CVR Agreement by and between PTI and the CVR Rep
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Form of Amended and Restated Executive Agreement
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2020
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2020
Offer Letter, dated August 3, 2018, by and between the Company and Sandra Zimmerman
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2018
ProteostasisTherapeutics, Inc. | 200 Technology Square, Fourth Floor, Cambridge, MA 02139 | T: 617 ###-###-####
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2017
Proteostasis Therapeutics, Inc. | 200 Technology Square, Fourth Floor, Cambridge, MA 02139 | T: 617 ###-###-####
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2016
Proteostasis Therapeutics, Inc. | 200 Technology Square, Fourth Floor, Cambridge, MA 02139 | T: 617 ###-###-####
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2016
Proteostasis Therapeutics, Inc. | 200 Technology Square, Fourth Floor, Cambridge, MA 02139 | T: 617 ###-###-####
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2016
Proteostasis Therapeutics, Inc. | 200 Technology Square, Fourth Floor, Cambridge, MA 02139 | ###-###-####
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2016
Proteostasis Therapeutics, Inc. | 200 Technology Square, Fourth Floor, Cambridge, MA 02139 | ###-###-####
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2016
THIRD AMENDED ANDRESTATED STOCKHOLDERS AGREEMENT
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2016
Void after 5:00p.m. New York Time on the Expiration Date (as defined below)
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2015